Tags: cancer, cell biology, cell cannibalism, developmental biology, entosiscell biology, mouse brain, neuroscience, single-cell RNA sequencing, spatial transcriptomicsImmunologyCancerMedical research
Profile | Contacts | Recent Articles on Subject | |
---|---|---|---|
1 | Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England | STAT+: Lung cancer drug from iTeos, GSK shows response, boosting TIGIT as a viable target - 5 days ago STAT+: FDA approves innovative T cell immunotherapy for rare soft-tissue cancer - about 2 months ago | |
2 | Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | ||
3 | Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA | Adaptimmune’s FDA Approval Marks the First for an Engineered Cell Therapy for Solid Tumors - about 2 months ago Artiva’s IPO Reels In $167M to Bring NK Cell Therapy to Autoimmune Diseases - about 2 months ago | |
4 | Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | FDA Greenlights First Engineered Cell Therapy for a Solid Tumor - about 2 months ago Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC - 2 months ago FDA OKs First Cellular Therapy for Melanoma - 7 months ago | |
5 | Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia | Is a better CAR-T cell therapy option on the horizon? - 2 months ago | |
6 | Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland | ||
7 | Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. | Tisa-Cel Yields Durable Responses in R/R Follicular Lymphoma - 9 months ago | |
8 | John Gever MedPage Today MedPage Today factotum. Pittsburgh, Pa. | ||
9 | Ian Ingram MedPage Today Deputy Managing Editor.
MedPage Today. New York, New York | FDA Approves Earlier Use of CAR-T Products for Myeloma - 5 months ago | |
10 | Damian Garde STAT News Biotech reporter at STAT. Open to messages. |